Biotechnology's "C"-Saw Year: Cialis Boosts Icos, Coviracil Costs Triangle
Executive Summary
Icos' upcoming NDA filing for the erectile dysfunction agent Cialis looks like the kind of new product milestone that is playing well with biotech investors heading into 2001.
You may also be interested in...
Postmarketing Requirement Increases In EU May Be Enforced By Fines
The European Commission may use fines to enforce increased postmarketing reporting requirements.
Postmarketing Requirement Increases In EU May Be Enforced By Fines
The European Commission may use fines to enforce increased postmarketing reporting requirements.
Bayer Comparing Vardenafil To Viagra In Attempt To Gain Edge In ED Market
Bayer is conducting comparative trials of vardenafil and Pfizer's Viagra (sildenafil) in an attempt to establish the benefits of its investigative drug over other erectile dysfunction agents.